21
Is it enough for biopharmaceutical companies to go overseas only by products? International market competition has shifted from "technical barriers" to "brand trust". The website is not only a product display window, but also a "digital business card" for an enterprise's internationalization strategy. How to make overseas users go from "cognition" to "trust", and finally achieve a win-win situation between the brand and the market? DTUY provides a one-stop optimization solution from technology adaptation to brand accumulation in response to the overseas website optimization needs of biopharmaceutical companies.
1. Technical optimization from the website infrastructure
The biomedical industry involves data and patented technology, and there are risks of data leakage and renewal when building a SaaS website. DTUY adopts independent server and exclusive data storage to ensure that the core data of the enterprise is independent and controllable throughout the process. For example, confidential information such as GMP certification documents and clinical trial data is isolated from external access through privatized encryption technology, and compliance requirements such as GDPR and HIPAA in Europe and the United States. At the same time, one-time construction and lifetime benefits avoid additional costs caused by system iteration, and truly transform the website into corporate brand equity.
2. Follow the target market for localization optimization
For the biomedical industry, products also have different market demands, and different localization optimization solutions are more likely to be trusted by users according to different markets. To this end, DTUY starts with these three points:
Keyword chain layer method: starting from core terms (such as "CAR-T therapy"), expanding long-tail words (such as "CAR-T clinical trials in Europe"), combined with AI tools to mine local search habits, to ensure that the content covers users from The full link from "cognition" to "decision-making".
Cultural compliance design: Avoid the use of animal experiment images in the Middle East, European and American pages need to highlight the EMA/FDA certification logo, and Southeast Asia needs to embed a "cost-efficacy" comparison chart.
Global content marketing: Through the construction of external links on authoritative platforms such as Google Scholar and PubMed, publish content such as industry and expert interviews, and shape the image of technical authority.
3. Optimize from the user's browsing website experience
Biomedical users have a long decision-making cycle, and they need to stay on the website more to better help users make decisions. Therefore, the website needs to take into account both professionalism and ease of use:
Extreme loading and mobile adaptation: Static technology is used to compress high-resolution image data, and the loading speed is increased by 40%; Responsive design adapts to high-frequency mobile scenarios such as doctors and researchers.
Intelligent retention system: Dynamically optimize the form fields according to user behavior (for example, only the mailbox is required for the first visit, and repeated visits trigger the "free technical consultation" entrance), and the retention rate of a customer increases by 55%.
AI customer service emotions: Embed multilingual intelligent customer service, automatically identify user consultation intentions (such as "cooperation inquiry" or "side effect feedback"), and communicate emotions in real time to improve response accuracy.
4. Optimize from the integrity of the website
DTUY tracks user click hotspots through heat maps, locates pages with high bounce rates (such as "patent application process"), and optimizes content structure using A/B testing. For example, after changing the "technical parameter table" to an interactive model, the page stay time of an enterprise is 70%. At the same time, combined with SEM agent operation services, keywords such as "CMO services for biopharmaceutical companies" are targeted in Google to achieve synergy between SEO and paid traffic.
At the beginning of 2025, more than 7 biopharmaceutical companies have signed contracts with DTUY, which shows that the international trade of biopharmaceutical companies is the general trend. Therefore, it is easier for companies to drive the market and brand by highly optimizing overseas websites. DTUY's one-stop overseas service can help biomedical companies realize the upgrade from "product" to "brand ". If you want to know more cases of enterprises going overseas, click the link below, fill in the contact, and get more information.
